A recent study has revealed that the endocannabinoid system may provide a novel treatment for alcoholism. Researchers have found that cannabinoid receptor 2 (CB2) is able to block the reward pathway for alcohol consumption.

Dampening the positive effects felt when consuming alcohol will hopefully lower the need to drink felt by those suffering from alcohol use disorders.

See the original article at CED Foundation